Drugs / STAN1
last change Dec 2017 re-read 3 minutes ago

STAN1

Developed for
celiac disease
Investigated by
Heim Pal Children's Hospital · Stanford University

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00962182 Aug 2008 → Dec 2014 celiac disease, dermatitis herpetiformis Heim Pal Children's Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as STAN1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00962182 ↗